Invex Therapeutics Ltd. (AU:IXC) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Invex Therapeutics Ltd has reported a change in the holdings of director Dr. Megan Baldwin, who disposed of 400,000 unlisted options and now holds 100,000 options exercisable at $0.87 with vesting conditions, via their related party GAJA Holdings. The change, described as a cancellation of unlisted options, took place on April 8, 2024.
For further insights into AU:IXC stock, check out TipRanks’ Stock Analysis page.